Meet TriadHLTH

Providing education, support, and guidance via person-centered health coaching + (AI) technology using our unique digital wellness programs.

Demand for GLP-1 diabetes and weight loss drugs like Ozempic, Wegovy, and Zepbound continues to rise, with the market for obesity drugs predicted to reach $77 billion by 2030.

Invest in your employees

When ranking their desired job benefits in order of importance, coverage for GLP-1 medications
such as Ozempic and Wegovy ranked behind only employee-sponsored health care, flexible working hours, company equity, and matching 401(k) contributions. It came in ahead of unlimited PTO, work-from-home or hybrid work, and childcare assistance.

Provide support that improves your ROI through sustainability of results

TriadHLTH programs work in three ways: Improving the user experience while taking GLP-1 medications, increasing the likelihood of overall compliance, creating a support system to maximize individual results, and developing lifestyle improvements that create sustained success and reduce an individual’s overall health risk profile.